DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

0.44 0.01 (2.33%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTX $0.44 2.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.44
Previous Close $0.43
Daily Range $0.41 - $0.46
52-Week Range $0.36 - $2.21
Market Cap $55.3M
P/E Ratio -0.78
Dividend (Yield) $0.00 (0.0%)
Volume 1,347,401
Average Daily Volume 1,847,434
Current FY EPS -$0.28

Sector

Healthcare

Industry

Drug Makers

Cytori Therapeutics, Inc. (USA) (CYTX) Description

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. Website: http://www.cytori.com/

News & Commentary Rss Feed

Fast and Furious Health Care Stocks This Week

MannKind, Cytori Therapeutics, and Omeros are among the health care stocks soaring this week.

Cytori Therapeutics (CYTX) Jumps: Stock Moves Up 10% - Tale of the Tape

Cytori Therapeutics (CYTX) Jumps: Stock Moves Up 10% - Tale of the Tape

Health Care Sector Update for 06/10/2015: IRWD, CYTX, HLS

Cytori Therapeutics' Preclinical Data for the Treatment of Thermal Injury Published in the Journal B

Cytori Therapeutics' Preclinical Data for the Treatment of Thermal Injury Published in the Journal Burns

Fluidigm Q1 Revenues Lower than Expected, Stock Down - Analyst Blog

Mettler-Toledo (MTD) Beats on Q1 Earnings, Sales; Stock Up - Analyst Blog

Ascendiant Capital Initiates Cytori Therapeutics With Buy

Benzinga's Top Initiations

Cytori Therapeutics (CYTX) Marc H. Hedrick on Q1 2015 Results - Earnings Call Transcript

Myriad Genetics Q3 Test Growth Impresses Yet Revenues Fall - Analyst Blog

NxStage Medical Loss Narrower than Expected, Revenues Up - Analyst Blog

See More CYTX News...

CYTX's Top Competitors

CYTX $0.44 (2.33%)
Current stock: CYTX
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB